US Generics

Alembic Pharmaceuticals Q1 Revenue Jumps 26% as US Generics Surge 49% YoY

Alembic Pharmaceuticals reports 26% YoY revenue growth to INR 2,150 Cr in Q1 FY27, driven by US Generics. Management raises full-year growth guidance to mid-teens.

Alembic Pharmaceuticals · 10 Aug 2026, 2:24 PM IST